Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 21, 2011


Marina Biotech has appointed John Fletcher to its board of directors.

Fletcher replaces Chiang Li, who co-founded Marina acquisition Cequent Pharmaceuticals. He is an independent director and founding partner of venture capital firm Fletcher Spaght Ventures.

Marina also said that board member James Karis has been appointed as chairman, replacing co-chairmen Gregory Sessler and Peter Parker, both of whom will continue as board members.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.